# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-25-032661
Filing Date
2025-11-03
Accepted
2025-11-03 08:00:38
Documents
20
Period of Report
2025-12-02

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEF 14A | bcda20251101_def14a.htm iXBRL | DEF 14A | 796525
6 |  | graph1.jpg | GRAPHIC | 51010
7 |  | graph2.jpg | GRAPHIC | 52151
8 |  | proxy_page2.jpg | GRAPHIC | 82591
9 |  | proxy_pg1.jpg | GRAPHIC | 101981
| Complete submission text file | 0001437749-25-032661.txt |  | 2138606

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | bcda-20241231.xsd | EX-101.SCH | 4575
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | bcda-20241231_def.xml | EX-101.DEF | 1750
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | bcda-20241231_lab.xml | EX-101.LAB | 1775
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | bcda-20241231_pre.xml | EX-101.PRE | 1004
22 | EXTRACTED XBRL INSTANCE DOCUMENT | bcda20251101_def14a_htm.xml | XML | 134395

Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38999 | Film No.: 251442162
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)